In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Cardiac remodelling in preadolescent endurance athletes assessed by traditional and three-dimensional echocardiography

Session Poster Session 1

Speaker Anders Wold Bjerring

Congress : ESC Congress 2018

  • Topic : preventive cardiology
  • Sub-topic : Athlete's Heart
  • Session type : Poster Session
  • FP Number : P651

Authors : AW Bjerring (Oslo,NO), HEW Landgraff (Oslo,NO), S Leirstein (Oslo,NO), A Aaeng (Oslo,NO), HZ Ansari (Oslo,NO), J Saberniak (Oslo,NO), K Murbrach (Oslo,NO), H Bruun (Oslo,NO), TM Stokke (Oslo,NO), KH Haugaa (Oslo,NO), J Hallen (Oslo,NO), T Edvardsen (Oslo,NO), SI Sarvari (Oslo,NO)

15 views

Authors:
A.W. Bjerring1 , H.E.W. Landgraff2 , S. Leirstein2 , A. Aaeng2 , H.Z. Ansari3 , J. Saberniak1 , K. Murbrach1 , H. Bruun3 , T.M. Stokke3 , K.H. Haugaa1 , J. Hallen2 , T. Edvardsen1 , S.I. Sarvari1 , 1Oslo University Hospital, Center for Cardiological Innovation - Oslo - Norway , 2Norwegian School of Sport Sciences - Oslo - Norway , 3Oslo University Hospital - Oslo - Norway ,

On behalf: Center for Cardiac Innovation

Citation:
European Heart Journal ( 2018 ) 39 ( Supplement ), 89

Background: Athlete's heart (AH) is a term used to describe exercise-induced cadiac remodelling in athletes. Recent studies suggest that these changes may occur even in preadolescence, but little is known of the initial morphological changes.

Purpose: This study aims to further describe the early morphological and functional changes in the hearts of endurance athletes by examining the hearts of preadolescent athletes using traditional and three-dimensional (3D) echocardiography.

Methods: Seventy-six cross-country skiers aged 12.1±0.2 years were compared to a control group of 25 non-competing individuals aged 12.1±0.3 years. Echocardiography was performed in all subjects, including 3D acquisitions of the left ventricle (LV). Relative wall thickness (RWT) was calculated by multiplying the LV posterior wall by two and dividing it by the LV internal diameter.

Results: The cross-country skiers had a significantly greater indexed VO2 max, septal thickness, posterior wall thickness and LV mass (Table). Athletes also had greater indexed LV diameters and higher RWT. Ejection fraction did not differ between the two groups.

Conclusion: Athletes had greater LV mass and LV chamber volumes, and also higher RWT compared to the controls. This supports the notion that there is early physiological, adaptive remodelling in preadolescent athlete's heart. Furthermore, remodelling in preadolescent athletes seems to be primarily concentric in nature.

Table 1
Athletes (n=76)Controls (n=25)P-value
VO2 max indexed, mL/kg/min62±744±5<0.001
IVSd, mm8±17±2<0.05
LVIDd/BSA, mm/m221±318±2<0.001
LVPWd, mm7±16±1<0.05
2D LV Mass/BSA, g/ m269±1257±13<0.001
3D LV EDV/BSA, mL75±770±6<0.01
3D LV ESV/BSA, mL33±430±4<0.01
3D LV Mass/BSA, g/m269±664±7<0.01
Relative wall thickness0.35±0.050.29±0.07<0.001
LV ejection fraction, %58±358±31.00
Data expressed as mean ± SD. Right column shows P-values for Student's t-test. BSA, body surface area; EDV, end-diastolic volume; ESV, end-systolic volume; IVSd, interventricular septum in diastole; LV, left ventricular; LVIDd, left ventricular internal diameter in diastole; LVPWd, left ventricular posterior wall in diastole; RWT, relative wall thickness.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are